Tuesday, 17 October 2006
Salon D-E (Doubletree Hotel at Reid Park)
317

Cytotoxic and other constituents of Streptomyces albofaciens

Bharat P. Bashyal, Christopher J. Seliga, Manping X. Liu, and A. A. Leslie Gunatilaka. University of Arizona, Tucson, AZ

Bioassay-guided fractionation of a cytotoxic EtOAc extract of the endophytic fungus Streptomyces albofaciens occurring in the leaf tissue of Agave parryi afforded two new natural products, cyclo (Tyr-Tryp) (1) and iso-streptimidone (2), and the known compounds, streptimidone (3), dealanylascamycin (4), and phenethylamide (5). The structures of 1 and 2 were elucidated by spectroscopic methods including 2D NMR. All compounds were evaluated for cytotoxicity in a panel of four human cancer cell lines [NCI-H460 (non-small cell lung), MCF-7 (breast), SF-268 (CNS glioma), MIA Pa Ca-2 (pancreatic carcinoma)] and normal human fibroblast cells (WI-38), and only 2 - 4 were found to be active. Dealanylascamycin (4) was highly active (IC50 = 0.02-1.01 µM) and was selective against all four cancer cell lines; its activity was found to be 30 to 50 times greater in cancer cell lines compared to the normal human fibroblast cells.

Back to Biochemistry Poster Session II
Back to The 19th Rocky Mountain Regional Meeting (October 14-18 2006)